Benzinga | Oct 28, 2020 04:37PM EDT

Amedisys Q3 Adj. EPS $2.24 Beats $1.28 Estimate, Sales $544.07M Beat $533.18M Estimate

Amedisys (NASDAQ:AMED) reported quarterly earnings of $2.24 per share which beat the analyst consensus estimate of $1.28 by 75 percent. This is a 94.78 percent increase over earnings of $1.15 per share from the same period last year. The company reported quarterly sales of $544.07 million which beat the analyst consensus estimate of $533.18 million by 2.04 percent. This is a 10.00 percent increase over sales of $494.63 million the same period last year.